Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(8):637-638; doi:10.1093/jnci/djh110
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Schernhammer, E.
Right arrow Articles by Fuchs, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Schernhammer, E.
Right arrow Articles by Fuchs, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: A Prospective Study of Aspirin Use and the Risk of Pancreatic Cancer in Women

Eva Schernhammer, Charles Fuchs

Affiliations of authors: Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

Correspondence to: Eva Schernhammer, MD, DrPH, Channing Laboratory, 181 Longwood Ave., Boston, MA 02115 (e-mail: eva.schernhammer@channing.harvard.edu)

The first 10% of the full text of this article appears below.

We thank Dr. Gensini et al. for their interesting contribution. They suggest that we, as well as other authors of observational studies, should always provide number needed to treat (NNT) and number needed to harm (NNH) to assess risk–benefit profiles for public health recommendations. Our analyses, based on data from the Nurses’ Health . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?